End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3.38 USD | 0.00% |
|
0.00% | -27.62% |
06-14 | Zura Bio Presents Data for the Tibulizumab (Zb-106) Program At Eular 2024 | CI |
06-06 | Zura Bio Limited Announces Formation of a Scientific Advisory Board | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-27.62% | 211M | |
+16.45% | 123B | |
+21.96% | 115B | |
+23.73% | 25.85B | |
-20.05% | 20.9B | |
-16.28% | 16.77B | |
-16.52% | 16.52B | |
-44.35% | 15.56B | |
+63.91% | 15.49B | |
+2.52% | 13.45B |
- Stock Market
- Equities
- ZURA Stock
- News Zura Bio Limited
- Chardan Initiates Zura Bio at Buy With $14 Price Target